store at low temperature
store at -80°C
Siltuximab(CNTO-328) is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 41,000 |
5 mg | 在庫あり | ¥ 101,000 |
10 mg | 在庫あり | ¥ 149,000 |
25 mg | 在庫あり | ¥ 226,500 |
50 mg | 在庫あり | ¥ 319,000 |
100 mg | 在庫あり | ¥ 429,500 |
説明 | Siltuximab(CNTO-328) is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19. |
In vivo | In xenograft mouse models, Siltuximab, when administered through intraperitoneal injection at a dosage of 10 mg/kg three times per week, inhibits the growth of lung cancer cells[1]. Furthermore, in a xenograft model, the growth of MCF-7 tumors is inhibited by Siltuximab with intraperitoneal injections at a dose of 20 mg/kg twice per week for 6 weeks[3]. |
別名 | CNTO-328 |
分子量 | N/A |
CAS No. | 541502-14-1 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Siltuximab 541502-14-1 Immunology/Inflammation IL Receptor CNTO-328 Inhibitor inhibitor inhibit